The Global Genetic Testing Market accounted for $3.2 billion in 2014 and is expected to grow at a CAGR of 9.26% to reach $6.5 billion by 2022. The factors contributing to the market growth include aging population, growing awareness, availability of direct to consumer tests and increasing incidence of genetic disorder. However factors such as high cost for testing and reimbursement issues are inhibiting the growth of the market. Genetic testing for cancer is likely to be the fastest growing segment during the forecast period. Increasing incidence of genetic diseases is providing more opportunities for genetic testing along with the rise in personalized medicine. The federal agencies who play a significant role in regulating genetic tests are Food and Drug Administration (FDA), Federal Trade Commission (FTC) and Center for Medicare and Medicaid services (CMS).
Global Genetic Testing Market is segmented on the basis of application and geography. By Application, the market is categorized into Cancer Genetic Testing Market, Prenatal Genetic Testing Market, Pharmacogenomics Genetic Testing Market and Predisposition Cancer Genetic Testing Market. By geography, market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America leads the Genetic Testing Market followed by Europe.
Some of the key players in Genetic Testing Market include Abbott Laboratories, Biocartis SA, Applied Biosystems Inc., Celera Group, AutoGenomics Inc., Roche Diagnostics Limited, IntegraGen S.A, Transgenomic, Inc., Molecular Inc. and Luminex Corporation.
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5Global Genetic TestingMarket, By Applications
5.1 Cancer Genetic Testing Market
5.2 Prenatal Genetic Testing Market
5.3 Pharmacogenomics Genetic Testing Market
5.4 Predisposition Cancer Genetic Testing Market
6 Global Genetic TestingMarket, By Geography
6.1 North America
6.1.1 US
6.1.2 Canada
6.2 Europe
6.2.1 Germany
6.2.2 France
6.2.3 Italy
6.2.4 UK
6.2.5 Spain
6.3 Asia Pacific
6.3.1 Japan
6.3.2 China
6.3.3 India
6.3.4 Australia
6.3.5 Newzealand
6.3.6 Rest of Asia
6.4 Rest of the World
6.4.1 Latin America
6.4.2 Middle East
6.4.3 Africa
6.4.4 Others
7 Key Developments
7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies
8 Company Profiling
8.1 Abbott Laboratories
8.2 Biocartis SA
8.3 Applied Biosystems Inc.
8.4 Celera Group
8.5 AutoGenomics Inc.
8.6 Roche Diagnostics Limited
8.7 IntegraGen S.A
8.8 Transgenomic, Inc.
8.9 Molecular Inc.
8.10 Luminex Corporation
List of Tables
1 Global Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
2 Global Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
3 Global Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
4 Global Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
5 Global Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
6 North America Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
7 North America Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
8 North America Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
9 North America Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
10 North America Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
11 Europe Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
12 Europe Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
13 Europe Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
14 Europe Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
15 Europe Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
16 Asia Pacific Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
17 Asia Pacific Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
18 Asia Pacific Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
19 Asia Pacific Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
20 Asia Pacific Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
21 Rest Of The World Genetic TestingMarket Outlook, By Applications (2012-2022) ($MN)
22 Rest Of The World Genetic TestingMarket Outlook, By Cancer Genetic Testing Market(2012-2022) ($MN)
23 Rest Of The World Genetic TestingMarket Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
24 Rest Of The World Genetic TestingMarket Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
25 Rest Of The World Genetic TestingMarket Outlook, By Predisposition Cancer Genetic Testing Market(2012-2022) ($MN)
